Antioxidant treatment can help lung disease patients: Study



[ad_1]

Administering an antioxidant-enriched vitamin may cause respiratory exacerbations in people with cystic fibrosis, a study suggests.

Cystic fibrosis is an inherited life-threatening disorder that damages the lungs and the digestive system.

The findings showed that supplementation with an oral antioxidant-enriched multi-vitamin was safe and well tolerated, and led to increased systemic antioxidant concentrations and decreased in systemic inflammation.

People with cystic fibrosis typically experience chronic bacterial infections, which lead to inflammation and the release of "large amounts of reactive oxygen species in the airways," said Scott D. Sagel, professor at the University of Colorado in the US. 19659002] While normally the body would have an antioxidant defense to neutralize this oxidant stress, cystic fibrosis is characterized by dietary antioxidant deficiency. This contribution to an oxidant-antioxidant has been reported in the American Journal of Respiratory and Critical Care Medicine (1965) for the study published in the American Journal of Respiratory and Critical Care Medicine. Nearly 100 patients for a 28-week study where 28 per cent of the antioxidant-treated group experienced 28 exacerbations.

The results showed a 50 per cent reduced risk to

"Improving antioxidant status in cystic fibrosis is an important clinical goal and may have a positive effect on health," Sagel said.

"While the antioxidant supplement did not appear to exert sustained anti-inflammatory effects, we believe that it is important to increase the rate of exacerbation. use.

"Developing safe and effective anti-inflammatory treatments remains a key priority of the cystic fibrosis community," he noted.

IANS

[ad_2]
Source link